Clinical Trials Logo

Clinical Trial Summary

Non-selective beta blockers are commonly used drugs for primary prevention and secondary prevention in patients with cirrhotic decompensated esophageal varices bleedingļ¼Œthe basic heart rate, blood pressure and condition of different patients have individual differences.This paper mainly discusses the compliance of patients taking NSBB under different follow-up methods and analyze the factors affecting patient compliance.


Clinical Trial Description

Esophagogastric variceal hemorrhage is a common complication of decompensated liver cirrhosis and the rate of rebleeding after hemostasis is high.Effective secondary prevention reduces the risk of rebleeding.Non-selective beta blockers are commonly used drugs for secondary prevention.Clinically, there is a great difference in the compliance of patients taking non-selective beta receptor blockers.In this study, the enrolled patients were divided into three groups: the traditional follow-up group (face-to-face interview);Non-traditional follow-up (WeChat, telephone, etc.);Traditional and non-traditional methods of follow-up were combined in the group.The investigators collected the basic data before the patients were enrolled, adjusted the medication dosage according to the patients' condition during the follow-up period, and recorded the treatment during the follow-up period, and analyzed the factors influencing the patients' compliance. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03683121
Study type Observational
Source Renmin Hospital of Wuhan University
Contact
Status Recruiting
Phase
Start date July 1, 2018
Completion date December 31, 2021

See also
  Status Clinical Trial Phase
Enrolling by invitation NCT05302661 - Effect of Re-education on Rebleeding Rate After Endoscopic Treatment in Liver Cirrhosis N/A